Webinar recordings

QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in hematological tumors

1,090 views
December 08, 2016
Hematological malignancies originating from hematopoietic and lymphoid tissue are complex heterogeneous diseases characterized by distinct clinicopathological features and molecular alterations. The heterogeneity of leukemia and lymphoma has presented massive challenges for identifying the appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond standard of care and chemotherapy. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of clinically actionable variants from NGS data in clinical genomics laboratories.

Related videos

Webinar recordings

Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characterization of the...

755 views December 20, 2016

High-throughput sequencing, combined with high-resolution metagenomic...

Webinar recordings

Part 1: Use of QCI Interpret to elucidate precision in breast cancer targeted therapy

837 views October 24, 2016

Breast cancer is a complex heterogeneous disease, with each subtype...

Webinar recordings

Genomics guided precision medicine with QCI Interpret: Discover how easy it is to standardize...

437 views June 20, 2018

Do you need a clinical reporting solution that is highly accurate,...